491 related articles for article (PubMed ID: 19392994)
1. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'.
Bousquet J; Burney PG; Zuberbier T; Cauwenberge PV; Akdis CA; Bindslev-Jensen C; Bonini S; Fokkens WJ; Kauffmann F; Kowalski ML; Lodrup-Carlsen K; Mullol J; Nizankowska-Mogilnicka E; Papadopoulos N; Toskala E; Wickman M; Anto J; Auvergne N; Bachert C; Bousquet PJ; Brunekreef B; Canonica GW; Carlsen KH; Gjomarkaj M; Haahtela T; Howarth P; Lenzen G; Lotvall J; Radon K; Ring J; Salapatas M; Schünemann HJ; Szczecklik A; Todo-Bom A; Valovirta E; von Mutius E; Zock JP
Allergy; 2009 Jul; 64(7):969-77. PubMed ID: 19392994
[TBL] [Abstract][Full Text] [Related]
2. [Global Allergy and Asthma European Network (GA2LEN) addresses the epidemic of allergy and asthma].
Panzer PC; van Cauvenberg P; Bousquet J
Cas Lek Cesk; 2010; 149(1):32-7. PubMed ID: 20662458
[TBL] [Abstract][Full Text] [Related]
3. [GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases].
Gjomarkaj M; Pace E; Canonica GW; Bonini S; Ricci G; Burney P; Zuberbier T; Van Cauwenberge P; Bousquet J
Minerva Med; 2009 Dec; 100(6):525-34. PubMed ID: 20010485
[TBL] [Abstract][Full Text] [Related]
4. [GA2LEN (Global Allergy and Asthma European Network)].
Bousquet J; Kauffmann F; Demoly P; Leynaert B; Bousquet PJ; Demenais F; Lenzen G; Burney PG; Zuberbier T; Van Cauwenberge P
Rev Mal Respir; 2009 Jun; 26(6):577-86. PubMed ID: 19623103
[TBL] [Abstract][Full Text] [Related]
5. [GA2LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers].
Wöhrl S; Radon K; Ring J; Moritz K; Akdis C; Burney P; Van Cauwenberge P; Bousquet J; Zuberbier T
Wien Klin Wochenschr; 2009; 121(17-18):589-97. PubMed ID: 19890749
[TBL] [Abstract][Full Text] [Related]
6. Spreading excellence in allergy and asthma: the GA2 LEN (Global Allergy and Asthma European Network) project.
Van Cauwenberge P; Watelet JB; Van Zele T; Bousquet J; Burney P; Zuberbier T;
Allergy; 2005 Jul; 60(7):858-64. PubMed ID: 15932373
[No Abstract] [Full Text] [Related]
7. Global Allergy and Asthma European Network (GA2LEN)--a focus for paediatric allergy research.
Warner JO
Pediatr Allergy Immunol; 2006 May; 17(3):163. PubMed ID: 16672001
[No Abstract] [Full Text] [Related]
8. European birth cohort studies on asthma and atopic diseases: II. Comparison of outcomes and exposures--a GA2LEN initiative.
Keil T; Kulig M; Simpson A; Custovic A; Wickman M; Kull I; Lødrup Carlsen KC; Carlsen KH; Smit HA; Wijga AH; Schmid S; Von Berg A; Bollrath C; Eller E; Bindslev-Jensen C; Halken S; Høst A; Heinrich J; Fantini MP; Brunekreef B; Krämer U; Willich SN; Wahn U; Lau S;
Allergy; 2006 Sep; 61(9):1104-11. PubMed ID: 16918514
[TBL] [Abstract][Full Text] [Related]
9. Establishing a standardized quality management system for the European Health Network GA2LEN.
Heinzerling L; Burbach G; van Cauwenberge P; Papageorgiou P; Carlsen KH; Lødrup Carlsen KC; Zuberbier T
Allergy; 2010 Jun; 65(6):743-52. PubMed ID: 19886923
[TBL] [Abstract][Full Text] [Related]
10. Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network.
Heinzerling L; Frew AJ; Bindslev-Jensen C; Bonini S; Bousquet J; Bresciani M; Carlsen KH; van Cauwenberge P; Darsow U; Fokkens WJ; Haahtela T; van Hoecke H; Jessberger B; Kowalski ML; Kopp T; Lahoz CN; Lodrup Carlsen KC; Papadopoulos NG; Ring J; Schmid-Grendelmeier P; Vignola AM; Wöhrl S; Zuberbier T
Allergy; 2005 Oct; 60(10):1287-300. PubMed ID: 16134996
[TBL] [Abstract][Full Text] [Related]
11. Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper.
Bousquet J; Anto J; Sunyer J; Nieuwenhuijsen M; Vrijheid M; Keil T; ; ; ;
Int Arch Allergy Immunol; 2013; 161(1):1-10. PubMed ID: 23258290
[TBL] [Abstract][Full Text] [Related]
12. European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs -- a GALEN initiative.
Keil T; Kulig M; Simpson A; Custovic A; Wickman M; Kull I; Lødrup Carlsen KC; Carlsen KH; Smit HA; Wijga AH; Schmid S; Berg A; Bollrath C; Eller E; Bindslev-Jensen C; Halken S; Høst A; Heinrich J; Porta D; Forastiere F; Brunekreef B; Krämer U; Willich SN; Wahn U; Lau S;
Allergy; 2006 Feb; 61(2):221-8. PubMed ID: 16409200
[TBL] [Abstract][Full Text] [Related]
13. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project.
Bousquet PJ; Demoly P; Romano A; Aberer W; Bircher A; Blanca M; Brockow K; Pichler W; Torres MJ; Terreehorst I; Arnoux B; Atanaskovic-Markovic M; Barbaud A; Bijl A; Bonadonna P; Burney PG; Caimmi S; Canonica GW; Cernadas J; Dahlen B; Daures JP; Fernandez J; Gomes E; Gueant JL; Kowalski ML; Kvedariene V; Mertes PM; Martins P; Nizankowska-Mogilnicka E; Papadopoulos N; Ponvert C; Pirmohamed M; Ring J; Salapatas M; Sanz ML; Szczeklik A; Van Ganse E; De Weck AL; Zuberbier T; Merk HF; Sachs B; Sidoroff A;
Allergy; 2009 Feb; 64(2):194-203. PubMed ID: 19178398
[TBL] [Abstract][Full Text] [Related]
14. GA2LEN--The Global Allergy and Asthma European Network.
Frew AJ
Clin Exp Allergy; 2005 Feb; 35(2):122-5. PubMed ID: 15725181
[No Abstract] [Full Text] [Related]
15. Meta-analysis of determinants for pet ownership in 12 European birth cohorts on asthma and allergies: a GA2LEN initiative.
Eller E; Roll S; Chen CM; Herbarth O; Wichmann HE; von Berg A; Krämer U; Mommers M; Thijs C; Wijga A; Brunekreef B; Fantini MP; Bravi F; Forastiere F; Porta D; Sunyer J; Torrent M; Høst A; Halken S; Lødrup Carlsen KC; Carlsen KH; Wickman M; Kull I; Wahn U; Willich SN; Lau S; Keil T; Heinrich J;
Allergy; 2008 Nov; 63(11):1491-8. PubMed ID: 18721248
[TBL] [Abstract][Full Text] [Related]
16. Developments in the field of allergy in 2010 through the eyes of Clinical and Experimental Allergy.
Katelaris CH; Linneberg A; Magnan A; Thomas WR; Wardlaw AJ; Wark P
Clin Exp Allergy; 2011 Dec; 41(12):1690-710. PubMed ID: 22107142
[TBL] [Abstract][Full Text] [Related]
17. [ECRIN (European clinical research infrastructures network), a pan-European infrastructure for clinical research].
Demotes-Mainard J
Bull Acad Natl Med; 2010 Dec; 194(9):1683-94. PubMed ID: 22043593
[TBL] [Abstract][Full Text] [Related]
18. The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations.
Magerl M; Borzova E; Giménez-Arnau A; Grattan CE; Lawlor F; Mathelier-Fusade P; Metz M; Młynek A; Maurer M;
Allergy; 2009 Dec; 64(12):1715-21. PubMed ID: 19793059
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of allergy syndromes: do symptoms always mean allergy?
Eigenmann PA
Allergy; 2005; 60 Suppl 79():6-9. PubMed ID: 15842226
[TBL] [Abstract][Full Text] [Related]
20. The AETL methodology as a potential solution to current challenges associated with the development and use of acute exposure levels in Seveso II applications.
Wood M; Pichard A; Gundert-Remy U; de Rooij C; Tissot SM
J Hazard Mater; 2006 May; 133(1-3):8-15. PubMed ID: 16343752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
